Non-invasive prenatal test that screens for recessive conditions and aneuploidies from a single maternal blood draw.
PrenatalUnity Complete is a non-invasive prenatal test (NIPT) using cell-free DNA from maternal blood at 9+ weeks to assess fetal risk for both recessive single-gene conditions and chromosomal aneuploidies. It is powered by BillionToOne's Quantitative Counting Template (QCT) technology, which quantifies single base-pair DNA variations with over 1,000x greater resolution than standard methods. It is the only NIPT capable of assessing both recessive disorders and aneuploidies from one blood draw. PrenatalUnity Complete is a product of BillionToOne.